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Abstract 
Obesity is associated with lower skeletal muscle capillarization and lower insulin sensitivity. Vascular endothelial 
growth factor (VEGF) is important for the maintenance of the skeletal muscle capillaries. To investigate whether 
VEGF and VEGF receptor [kinase insert domain- containing receptor (KDR) and Flt-1] expression are lower 
with obesity, vastus lateralis muscle biopsies were obtained from eight obese and eight lean young sedentary men 
before and 2 h after a 1-h submaximal aerobic exercise bout for the measurement of VEGF, KDR, Flt-1, and 
skeletal muscle fiber and capillary characteristics. There were no differences in VEGF or VEGF receptor mRNA 
at rest between lean and obese muscle. Exercise increased VEGF (10-fold), KDR (3-fold), and Flt-1 (5-fold) 
mRNA independent of group. There were no differences in VEGF, KDR, or Flt-1 protein between groups. 
Compared with lean skeletal muscle, the number of capillary contacts per fiber was the same, but lower capillary 
density (CD), greater muscle cross sectional area, and lower capillary-to-fiber area ratio were observed in both 
type I and II fibers in obese muscle. Multiple linear regression revealed that 49% of the variance in insulin sensi- 
tivity (homeostasis model assessment) could be explained by percent- age of body fat (35%) and maximal oxygen 
uptake per kilogram of fat-free mass (14%). Linear regression revealed significant relation- ships between 
maximal oxygen uptake and both CD and capillary-to- fiber perimeter exchange. Although differences may exist 
in CD and capillary-to-fiber area ratio between lean and obese skeletal muscle, the present results provide 
evidence that VEGF and VEGF receptor expression are not different between lean and obese muscle. 
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 Obesity is associated with lower skeletal muscle capillarization 
and lower insulin sensitivity. Vascular endothelial growth factor 
(VEGF) is important for the maintenance of the skeletal muscle 
capillaries. To investigate whether VEGF and VEGF receptor [kinase 
insert domain- containing receptor (KDR) and Flt-1] expression are 
lower with obesity, vastus lateralis muscle biopsies were obtained 
from eight obese and eight lean young sedentary men before and 2 h 
after a 1-h submaximal aerobic exercise bout for the measurement of 
VEGF, KDR, Flt-1, and skeletal muscle fiber and capillary 
characteristics. There were no differences in VEGF or VEGF receptor 
mRNA at rest between lean and obese muscle. Exercise increased 
VEGF (10-fold), KDR (3-fold), and Flt-1 (5-fold) mRNA independent 
of group. There were no differences in VEGF, KDR, or Flt-1 protein 
between groups. Compared with lean skeletal muscle, the number of 
capillary contacts per fiber was the same, but lower capillary density 
(CD), greater muscle cross sectional area, and lower capillary-to-fiber 
area ratio were observed in both type I and II fibers in obese muscle. 
Multiple linear regression revealed that 49% of the variance in insulin 
sensi- tivity (homeostasis model assessment) could be explained by 
percent- age of body fat (35%) and maximal oxygen uptake per 
kilogram of fat-free mass (14%). Linear regression revealed 
significant relation- ships between maximal oxygen uptake and both 
CD and capillary-to- fiber perimeter exchange. Although differences 
may exist in CD and capillary-to-fiber area ratio between lean and 
obese skeletal muscle, the present results provide evidence that VEGF 
and VEGF receptor expression are not different between lean and 
obese muscle. 
kinase insert domain-containing receptor; Flt-1; exercise; homeostasis 
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OBESITY IS A MAJOR HEALTH PROBLEM in the United States and 
many other industrialized countries. Increasing adiposity is 
associated with lower skeletal muscle oxidative capacity and 
capillarization (22). Skeletal muscle capillaries are a funda- 
mental component in the diffusion of various substances in- 
cluding oxygen, glucose, insulin, and fatty acids from the 
circulation to skeletal muscle (18). 
The transcapillary delivery of insulin and glucose is mediated 
through passive diffusion. Fick’s law of diffusion states that the 
amount of substance transferable via diffusion is directly propor- 
tional to the surface area available for diffusion and the concen- 
tration gradient of substance of interest, and is inversely propor- 
tional to diffusional distance. Therefore, an increase in the con- 
centration gradient should increase the diffusion of substance 
across the capillary membrane, unless a limit exists as a result of 
the surface area or diffusional distance. Transcapillary transport of 
insulin is an important contributor to insulin sensitivity (2). In 
muscle, an increase in plasma insulin does not increase the 
concentration of insulin in the interstial space between the capil- 
lary and muscle fi (11), suggesting that a limit may exist in the 
diffusional conductance of insulin in skeletal muscle. In obese 
muscle, a lower muscle capillary-to-fi area ratio (CFA) is 
associated with lower insulin action (21). Compared with lean, 
obese individuals demonstrate a delayed transport of insulin over 
the capillary wall (31), which may be attributed to lower skeletal 
muscle capillary density (CD) in obese muscle. 
Present data suggest that vascular endothelial growth factor 
(VEGF) is an important regulator of skeletal muscle capillaries. 
Inhibition of endogenous VEGF production reduces skeletal mus- 
cle capillarization by 64% (32). Blockade of VEGF during 
chronic electrical stimulation or exercise training inhibits skeletal 
muscle angiogenesis (3, 4). There are no differences in circulating 
VEGF between lean and obese individuals (27); however, myo- 
cardial VEGF expression and VEGF receptor 2 [kinase insert 
domain-containing receptor (KDR) human/Flk-1 murine analog], 
but not VEGF receptor 1 (Flt-1) are lower in obese compared with 
lean Zucker rats (7, 33). Whether VEGF or VEGF receptor 
expression is lower in obese human muscle at rest or whether the 
VEGF or VEGF receptor responses to acute aerobic exercise are 
lower in obese human vastus lateralis muscle is unknown. Ac- 
cordingly, the present study was designed to investigate the 
hypothesis that obesity alters resting and exercise-induced expres- 
sion of VEGF and VEGF receptors in human muscle. 
METHODS 
Subjects. Eight sedentary lean (LM; range 19.0 –25.0 body mass 
index) and eight sedentary obese men (OM; range 31.8 – 47.4 body 
mass index) volunteered to participate in the study after written and 
verbal explanations of the content and intent of the study were given 
in accordance with the University & Medical Center Institutional 
Review Board. All subjects were healthy, nonsmokers, with no history 
of cardiopulmonary disease or diabetes, and completed a physical 
activity readiness questionnaire before commencement of the study. 
Subject characteristics are listed in Table 1. 
Maximal oxygen consumption. Maximal  oxygen  consumption 
(V̇ O2 max) was measured on an electronically braked cycle ergometer 
(Lode, Excaliber Sport, Groningen, The Netherlands) by open-circuit 
Table 1. Subject characteristics cryostat, mounted on slides, and kept at -20°C until fixation. Sections 
were stained for capillaries using a modified ATPase method (Rosen- 
blatt technique; Ref. 29), which simultaneously provides fiber typing 
(type I and II) and capillary visualization. There is no difference in the 
number of capillaries visualized with frozen biopsy samples using the 
Rosenblatt technique and the number visualized in tissue sections 
prepared from perfusion-fixed muscle (15). 
Muscle sections were viewed under a light microscope (Nikon 400) 
at a magnifi of X200, and a digital image was taken of the section 
(Nikon Coolpix 990). Capillaries were quantifi manually from the 
digital image on individual fi  The following indexes were measured 
(13): 1) the number of capillaries around a fi     [capillary contacts (CC)], 
2) the capillary-to-fi ratio on an individual-fi basis (C/Fi), 3) the 
number of fi sharing each capillary (sharing factor), and 4) CD. 
Capillary-to-fi perimeter exchange index (CFPE) was calculated as an 
estimate of the capillary-to-fi     surface area (13), whereas the capillary- 
Values are means ± SE. N = 8 men/group. BMI, body mass index. V̇ O2max, 
maximal oxygen consumption; Maximum PO, power output at V̇ O2max; 
HOMA, homeostasis model assessment. 
spirometry (True Max 2400, Parvo Medics, Salt Lake City, UT). The 
test began with a 5-min warm-up at 75 W. After the warm-up, the 
workload was increased 25 W every 2 min until volitional fatigue. 
Body composition. Body density was determined via hydrostatic 
weighing. Residual volume was measured by oxygen dilution (36). 
Body fat percentage was determined from body density based on the 
two-compartment model of Siri et al. (30). 
Submaximal exercise and muscle biopsies. At least 1 wk after the 
V̇ O2 max test, subjects completed  1  h of exercise at 50% V̇ O2 max. 
Before the commencement of exercise and at 2 h postexercise, a 
muscle biopsy was obtained from the vastus lateralis. The resting and 
postexercise muscle biopsy samples were obtained from alternate 
legs. Samples were stored at -80°C until analysis. A section of the 
resting sample was oriented in an optimal cutting temperature (OCT) 
compound (Sakura Finetek, Torrance, CA) and tragacanth (Sigma, St. 
Louis, MO) mixture, frozen in liquid nitrogen-cooled isopentane, and 
stored at -80°C until processing for the measurement of muscle 
morphometry and capillarization. 
Insulin and glucose. Insulin and glucose were determined from a 
12-h fasting plasma sample by an immobilized enzyme biosensor for 
glucose (YSI 2300 STAT plus glucose and lactate analyzer, Yellow 
Spring Instruments, Yellow Springs, OH) and by chemiluminescent 
enzyme immunoassay for insulin (Access, Beckman Coulter, Brea, CA) 
according to the manufacturer’s instructions. The homeostasis model 
assessment (HOMA) allows for the quantitative assessment of insulin 
action using fasting concentrations of glucose and insulin. The formula is 
based on an array of predicted glucose and insulin values that would be 
expected for many potential combinations of insulin action (23). 
RNA isolation and Northern analysis. Total cellular RNA was 
isolated from each biopsy sample, and standard Northern blot analysis 
was performed for VEGF, KDR, and Flt-1 mRNA as previously 
described (10). Blots were exposed to XAR-5 X-ray film (Eastman 
Kodak, New Haven, CT) by use of a Cronex Lightning Plus screen at 
-80°C. Autoradiographs were quantitated by densitometry within the 
linear range of signals and normalized to r3-actin mRNA levels. 
Protein isolation and analysis. A portion of the muscle biopsy 
sample was homogenized in RIPA (1X PBS, 1% Igepal, 0.5% sodium 
deoxycholate, 0.1% SDS with protease inhibitors) as previously 
described (10). Total protein was measured by bicinchoninic acid 
(Bio-Rad Laboratories, Hercules, CA). For each sample, VEGF (from 
50 µg of total protein), KDR (from 125 µg of total protein), and Flt-1 
(from 50 µg of total protein) were measured in duplicate. Commercial 
VEGF, KDR, and Flt-1 ELISA kits were used according to the 
manufacturer’s instructions and within the linear range of the kits 
(R&D Systems, Minneapolis, MN). 
Morphometric and morphological analysis. Muscle tissue mounted 
in  OCT  tragacanth  was  sectioned  to  a  thickness  of  10  µm  on  a   
to-fi area ratio (CFA) was calculated as an estimate of the muscle fi 
area supplied by a capillary (21). The sampling strategy employed for 
image capture involved randomly selecting two to three fi from the 
muscle biopsy sample as previously described by Hepple et al. (16). For 
each image collected, a sampling frame was created within the image, 
such that all fi intersecting the edges of the sampling frame were 
contained completely within the image. By allowing the complete area of 
all fi wholly or partially contained within the sampling frame to be 
measured, this technique prevents bias of the data toward smaller fi  
that would otherwise occur due to the fact that smaller fi have a 
greater probability than larger fi of being completely contained within 
the image (16). Quantifi of skeletal muscle capillarization was 
Fig. 1. Representative Northern blot (A) and quantitative densitometry for the 
ratio of vascular endothelial growth factor (VEGF) mRNA to r3-actin mRNA 
(B) in skeletal muscle of lean (L) and obese (O) men at rest and 2 h after the 
completion of 1 h of cycle ergometer exercise. Lean rest data were normalized 
to 1.0. All other data were normalized to lean + rest to allow for comparisons. 
VEGF was significantly increased by exercise. There was no difference in 
VEGF mRNA between lean and obese men. Error bars represent standard 
errors. N = 8 men/group. 
Lean Obese P Value 
Age, yr 23±1 22±1 0.223 
Height, cm 175.5±2.0 179.6±2.8 0.250 
Mass, kg 68.8±3.0 117.0±7.6 0.000 
Body fat, % 17.3±1.5 31.1±2.9 0.001 
BMI 22.4±1.1 36.2±1.9 0.000 
Rest systolic blood pressure, mmHg 113.0±3.2 126.3±3.9 0.080 
Rest diastolic blood pressure, mmHg 78.0±2.4 83.7±2.1 0.191 
V̇ O2max, ml O2·kg-1·min-1 40.2±1.5 29.7±1.5 0.000 
V̇ O2max, ml O2·kg FFM-1·min-1 48.6±1.2 43.5±2.2 0.055 
Maximum PO, W 231±10 256±12 0.141 
Fasting glucose, mM 4.58±0.16 5.16±0.23 0.057 
Fasting insulin, µU/ml 6.57±2.44 14.62±2.23 0.029 







Fig. 2. Representative Northern blot and 
quantitative densitometry for the ratio of 
kinase insert domain-containing receptor 
(KDR; A) and Flt-1 (B) mRNA to r3-actin 
mRNA in skeletal muscle of lean (L) and 
obese (O) men at rest and 2 h after the 
completion of 1  h of cycle ergometer exer- 
cise. Lean rest data were normalized to 1.0. 
All other data were normalized to lean + 
rest to allow for comparisons. KDR and 
Flt-1 mRNA were significantly increased by 
exercise. There were no differences in KDR 
or Flt-1 mRNA between lean and obese men. 







performed on at least 50 fi       (mean 56.0 ± 2.0 fi since a 
greater sampling size does not improve the estimation of capillarization in 
human skeletal muscle (26). Fiber cross-sectional area (FCSA) and 
perimeter were measured with the image-analysis system and commer- 
cial software (SigmaScan, Jandel Scientifi calibrated to transform the 
number of pixels (viewed on a computer monitor) into micrometers. 
Statistical treatment. For both mRNA and protein, a two-way 
analysis of variance (group X exercise level) was used. After a 
significant F ratio, a Bonferroni post hoc analysis was used. Unpaired 
Student’s t-tests were used to compare differences in all other vari- 
ables. Multiple linear regression was performed to identify relation- 
ships between variables. One resting mRNA sample was lost for LM 
and one from OM, and these samples were not replaced. Significance 
was established at P < 0.05 for all statistical sets, and data are 




Subject characteristics. OM demonstrated significantly 
lower V̇ O2 max than LM (LM: 40.2 ± 1.5 ml O2 · kg-1 · min-1; 
OM: 29.7 ± 1.5 ml O2 · kg-1 · min-1); however, when cor- 
rected for fat-free mass (FFM), the difference in V̇ O2 max was 
no longer statistically significant (P = 0.055) (Table 1). OM 
demonstrated greater fasting insulin than LM (LM: 6.57 ± 
2.44 µU/ml; OM: 14.62 ± 2.23 µU/ml) and HOMA (LM: 
1.24 ± 0.37; OM: 3.49 ± 0.63) (Table 1). 
VEGF and VEGF receptor expression. In Figs. 1 and 2, 
mRNA at rest and in response to acute systemic exercise for 
VEGF (Fig. 1), KDR (Fig. 2A), and Flt-1 (Fig. 2B) are shown 











Fig. 3.  Skeletal muscle protein for VEGF 
(A), KDR (B), Flt-1 (C), and KDR-to-Flt-1 
ratio (D) at rest and 2 h after the completion 
of  1  h of cycle ergometry exercise. There 
were no differences in VEGF, KDR, Flt-1, 
or KDR/Flt-1 between lean and obese men. 













Type I fibers, % 38.8±4.7 37.7±2.8 0.842 
Area of type I fibers, % 35.5±4.2 33.1±2.4 0.626  
Values are means ± SE. N = 8 men/group. 
 
etry normalized to r3-actin mRNA. The expression of mRNA 
was analyzed at rest and 2 h after a single, 1-h submaximal 
exercise bout in the vastus lateralis. Systemic exercise in- 
creased VEGF mRNA, KDR mRNA, and Flt-1 mRNA inde- 
pendent of group. 
VEGF, KDR, Flt-1, and the KDR/Flt-1 protein at rest and in 
response to acute systemic exercise are shown in Fig. 3. There 
were no differences in VEGF, KDR, Flt-1, or KDR/Flt-1 ratio 
between groups. 
Muscle morphology. In type I fibers, OM demonstrated 
larger muscle FCSA (LM: 4,273 ± 311 µm2; OM: 5,936 ± 
498 µm2) and perimeter (LM: 275.8 ± 11.5 µm; OM: 324.8 ± 
15.0 µm) than LM (Table 2). Despite the larger fibers, there 
were no differences in CC, C/Fi, sharing factor, or CFPE 
between groups (Table 3). Both CD (LM: 277.4 ± 13.0 
capillaries/mm2; OM: 217.0 ± 17.8 capillaries/mm2) and CFA 
(LM: 2.67 ± 0.12 capillaries/10,000 µm2; OM: 2.10 ± 0.18 
capillaries/10,000 µm2) were lower in OM. 
In type II fibers, FCSA (LM: 4,924 ± 256 µm2; OM: 
7,182 ± 399 µm2) and perimeter (LM: 295.8 ± 7.2 µm; OM: 
359.2 ± 11.5 µm) were larger in OM. As in type I fibers, there 
were no differences in CC, C/Fi, sharing factor, or CFPE 
between groups, but CD (LM: 252.3 ± 11.5 capillaries/mm2; 
OM: 198.8 ± 17.7 capillaries/mm2) and CFA (LM: 2.47 ± 
0.12 capillaries/10,000 µm2; OM: 1.93 ± 0.18 capillaries/ 
10,000 µm2) were lower in OM. Representative photomicro- 
graphs from lean and obese muscle are in Fig. 4. 
Insulin action, V̇ O2 max, and skeletal muscle capillaries. Mul- 
tiple linear regression revealed that body composition (body fat 
%) (P = 0.008 to enter) can account for 35% of the variance 
in HOMA, whereas V̇ O2 max as expressed per kilogram FFM 
(P = 0.049 to enter) can account for an additional 14% of the 
variance in HOMA [HOMA = (0.110 X body fat %) - 
(0.136 X V̇ O2 max kg FFM) + 5.97; overall adjusted R2 = 
0.49]. There were no significant relationships identified be- 
tween any measure of skeletal muscle capillarization and 
HOMA. 
Regression revealed  a  significant  relationship  between 
V̇ O2 max and CD (Fig. 5A). When V̇ O2 max was expressed per 
kilogram FFM, regression revealed significant relationships 




The principal fi  of the present study is that VEGF, KDR, 
and Flt-1 expression are similar in young LM and OM at rest and 
in acute aerobic exercise. In addition, we have also shown that 
measures of capillarization independent of FCSA (CC, C/Fi, and 
CFPE) are not different between lean and obese muscle, whereas 
measures accounting for FCSA (CD and CFA) are lower in obese 
muscle. The present result of lower CD in obese muscle is 
consistent with the relationship previously observed between CD 
and body fat % (r =-0.59) by Lillioja et al. (22). We are unaware 
of any reports that have compared measures of capillarization that 
do and do not account for FCSA in lean and obese muscle. 
Obesity and basal VEGF and VEGF receptor expression. In 
Zucker rats, myocardium from obese animals demonstrates 
lower VEGF and VEGF receptor 2 mRNA expression com- 
pared with lean animals (7). There is a positive correlation 
between myocardial VEGF expression and CD in obese Zucker 
rats (33), suggesting that lower VEGF is responsible for the 
lower capillary supply observed in obese myocardium. We did 
not observe any differences in VEGF or VEGF receptor 
mRNA or protein expression between lean or obese skeletal 
muscle, which is consistent with the similar values for CC and 
C/Fi observed between lean and obese muscle but inconsistent 
with the lower CD and CFA. 
 
Table 3. Skeletal muscle capillary supply characteristics  
 Lean Obese P Value 
Overall capillary contacts 3.12±0.14 3.43±0.30 0.363 
Type I capillary contacts 3.01±0.21 3.18±0.26 0.608 
Type II capillary contacts 3.16±0.13 3.59±0.34 0.260 
Overall individual capillary-to-fiber ratio 1.19±0.06 1.31±0.12 0.358 
Type I individual capillary-to-fiber ratio 1.14±0.09 1.21±0.09 0.586 
Type II individual capillary-to-fiber ratio 1.20±0.05 1.38±0.14 0.269 
Overall sharing factor 2.76±0.06 2.76±0.04 0.937 
Type I sharing factor 2.78±0.07 2.77±0.04 0.934 
Type II sharing factor 2.76±0.06 2.75±0.05 0.932 
Overall capillary density, capillaries/mm2 266.9±10.5 206.8±18.0 0.012 
Type I capillary density, capillaries/mm2 277.4±13.0 217.0±17.8 0.016 
Type II capillary density, capillaries/mm2 252.3±11.5 198.8±17.7 0.024 
Overall CFPE, capillaries/1,000 µm 4.12±0.15 3.80±0.32 0.382 
Type I CFPE, capillaries/1,000 µm 4.08±0.20 3.75±0.27 0.332 
Type II CFPE, capillaries/1,000 µm 4.06±0.15 3.82±0.36 0.543 
Overall CFA, capillaries/10,000 µm2 2.58±0.10 1.99±0.18 0.013 
Type I CFA, capillaries/10,000 µm2 2.67±0.12 2.10±0.18 0.021 
Type II CFA, capillaries/10,000 µm2 2.47±0.12 1.93±0.18 0.026 
Values are means ± SE. CFPE, capillary-to-fiber perimeter exchange index; CFA, capillary-to-fiber area. N = 8 men/group. 
 
Lean Obese P Value 
Overall fiber area, µm2 4,618±220 6,694±426 0.001 
Type I fiber area, µm2 
Type II fiber area, µm2 










Type I fiber perimeter, µm 275.8±11.5 324.8±15.0 0.021 






Fig. 4. Photomicrographs of muscle stained for capillaries in young lean (A) 
and obese (B) men. Capillaries appear as dark-stained regions between fibers. 
Type I fibers stain as dark and type II fibers stain as light. Bar = 50 µm. 
 
Obesity, exercise, and VEGF and VEGF receptor expres- 
sion. Exercise is a stress to muscle that produces an increase in 
the capillary supply (5, 6, 28). Consistent with this, acute 
aerobic exercise increases VEGF mRNA in human muscle (10, 
12, 17, 19, 28, 35). In the present study, exercise increased 
VEGF, KDR, and Flt-1 mRNA independent of group, suggest- 
ing that the regulation of VEGF and VEGF receptor expression 
in obese muscle in response to aerobic exercise is not different 
than in lean muscle. This is consistent with findings that the 
capillary supply is increased in response to aerobic exercise 
training in obese muscle (21). 
Muscle fiber size and capillarization. It has been proposed 
that the size of the capillary supply is loosely related to muscle 
fiber size (8). In the present study, OM demonstrated larger 
FCSA indicative of muscle fiber hypertrophy in both type I and 
type II fibers compared with lean muscle. Despite these larger 
fibers, the number of capillaries expressed as either CC or C/Fi 
was not different between groups, and as a result CFA was 
lower in OM. This is in contrast to the results obtained in 
young men in response to resistance exercise-induced muscle 
hypertrophy where CFA is well maintained (24). Thus obese 
muscle may demonstrate a reduced angiogenic response to 
muscle fiber hypertrophy. 
Recent work suggests that small increases in muscle VEGF 
can promote physiological angiogenesis (25). Therefore, it 
might be hypothesized that greater VEGF protein expression in 
obese muscle could lead to an increase in capillarization and 
maintain the capillary-to-fiber size relationship observed in 
lean muscle and in response to resistance exercise-induced 
muscle hypertrophy (24). To our knowledge, there are no 
studies investigating the effects of resistance exercise on an- 
giogenesis in obese muscle. 
In the present study, individuals performed aerobic exercise 
to investigate whether VEGF and VEGF receptor responses to 
exercise are lower in obese muscle. It is possible that, although 
the VEGF and VEGF receptor responses to aerobic exercise 
are similar between lean and obese muscle, the response to 




Fig. 5. Linear regression  between  relative  maximal  oxygen  consumption 
(V̇ O2 max) per kilogram and capillary density (A) and between relative V̇ O2 max 
per kilogram FFM and capillary density (B) and capillary-to-fiber perimeter 
exchange index (CFPE; C), demonstrating that capillary supply is an important 
determinant of aerobic capacity in young sedentary men. N = 16 men. 
 
 
cise does promote increases in VEGF mRNA in human muscle 
(20). In rats, VEGF mRNA and protein are increased during 
compensatory muscle hypertrophy (9). Whether obese muscle 
demonstrates a reduced VEGF response to acute resistance 
exercise is unknown. 
Regulation of V̇ O2 max. The most prominent theory on the 
regulation of the capillary supply suggests that the size of the 
capillary supply is proportional to the metabolic demand of the 
muscle fiber (1). According to Fick’s law of diffusion, an 
increase in the capillary-to-fiber surface area (CFPE estimates 
the capillary-to-fiber surface area) or a reduction in diffusional 
distance (CD estimates diffusional distance) will improve dif- 
fusional conductance from the capillary lumen to the muscle 
cell membrane for substances such as oxygen and insulin (18, 
34). In support of the metabolic regulation of the capillary 
supply,   significant   relationships   were   identified   between 
V̇ O2 max, CD, and CFPE, suggesting that the capillary supply is 
appropriately regulated in lean and obese muscle to match 
metabolic demand. Although it has been suggested that capil- 
lary-to-fiber surface area is more tightly regulated than diffu- 
sional distance (14), evaluations such as this are not possible 
from the present data. 
Regulation of insulin action. It is well known that both 
aerobic capacity and body composition are positively corre- 
lated with insulin action (18). Consistent with this, multiple 
linear regression did reveal relationships between insulin ac- 
tion, body composition, and aerobic capacity in the present 
report. In contrast, there were no relationships identified be- 
tween any measure of the capillary supply and insulin action, 
which is in contrast to Lillioja et al. (22). Differences between 
our data and that of Lillioja et al. may arise due to differences 
in the measurement technique used to assess insulin sensitivity 
(HOMA vs. euglycemic clamp, respectively) or the size and 
the composition of the sampled populations (two distinct pop- 
ulations of lean/obese and a cross-sectional design, respec- 
tively). 
In summary, we have demonstrated that basal and acute 
aerobic exercise-induced VEGF and VEGF receptor expres- 
sion are not altered in obese skeletal muscle. We have also 
demonstrated a lower CD and CFA in obese muscle but no 
difference in absolute capillary numbers or CFPE (an estimate 
of the capillary-to-fiber interface), raising questions as to the 
variables regulating the capillary supply in obese muscle. 
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